Johnson & Johnson seeks emergency use approval for its single-dose Covid vaccine

Johnson & Johnson seeks emergency use approval for its single-dose Covid vaccine
Premium
Johnson & Johnson has asked U.S. regulators to clear the world’s first single-dose COVID-19 vaccine, an easier-to-use option that could boost scarce supplies
(AP)
Johnson & Johnson's vaccine would be the third authorized US, after those of Pfizer-BioNTech and Moderna
The vaccine was overall 66% effective, the company said. And it is 85% effective in preventing severe forms of the disease
Share Via
Read Full Story
Pharma giant Johnson & Johnson on Thursday sought emergency use authorization (EUA) of its Covid-19 vaccine from US health authorities, the company said in a statement.

Related Keywords

South Africa , Australia , North Korea , United States , Mumbai , Maharashtra , India , Paul Stoffels , Pfizer , Korean Central News Agency , European Medicines Agency , Johnson , Emergency Use Authorization , Vice Chairman , Executive Committee , Chief Scientific Officer , Conditional Marketing Authorisation Application , Join Mint , Johnson Covid Vaccine , Covid Vaccine Approval , Moderna , ஆஸ்திரேலியா , வடக்கு கொரியா , ஒன்றுபட்டது மாநிலங்களில் , மும்பை , மகாராஷ்டிரா , இந்தியா , ஃபைசர் , ஜான்சன் , அவசரம் பயன்பாடு அங்கீகாரம் , துணை தலைவர் , நிர்வாகி குழு , தலைமை அறிவியல் அதிகாரி , சேர புதினா , மாடர்னா ,